Background
Pharmacist‐driven transition of care (TOC) initiatives have been shown to reduce rates of medication errors and readmission rates in several patient populations, including heart failure. Existing literature evaluating pharmacist‐driven TOC initiatives targeting patients with acute coronary syndromes (ACSs) are limited.
Objective
To assess the impact of a newly implemented pharmacist‐driven TOC initiative on readmission rates in patients with ACS.
Methods
This was a retrospective, single‐center, pre‐post observational cohort study. Institutional review board approval was obtained. Patients were matched for age, gender, and ACS type with a historical cohort who received no pharmacist TOC intervention. The primary outcome was the 90‐day all‐cause readmission rate. Secondary outcomes included 30‐ and 90‐day cardiovascular‐related readmission rates as well as the 30‐day all‐cause readmission rate. Individual components of a pharmacist‐driven TOC initiative were also evaluated to determine what, if any, aspect of the program had the greatest association with reduced readmission.
Results
A total of 300 patients were included in the study; 150 patients in the pharmacist TOC group and 150 patients in the historical control group. There was a statistically significant reduction in all readmissions at 90 days in the pharmacist TOC group compared with the historical control group (24.7% vs 13.3%, P = .0124). Cardiovascular‐related readmissions were also significantly reduced in the pharmacist TOC group at 30 days (11.3% vs 4.7%, P = .0333) and at 90 days (16.7% vs 8.0%, P = .0225). A higher percentage of patients who were not readmitted received pharmacist medication history and reconciliation compared with patients who were readmitted (129 [99.2%] vs 18 [90%], respectively, P = .046).
Conclusions
The implementation of a pharmacist‐driven TOC initiative targeting ACS patients was associated with reduced readmission rates.